Professional Team and Facilities Awards and Social Responsibility
We are one of the leading ophthalmic service providers in Hong Kong and Guangdong Province established under the brand of “C-MER Dennis Lam (希瑪林順潮)”. Headquartered in Hong Kong, we became the first foreign investor to wholly own an eye hospital in the PRC. Our Shenzhen C-MER Dennis Lam Eye Hospital (深圳希瑪林順潮眼科醫院), established in March 2013, is the first and as of the Latest Practicable Date, the only Hong Kong privately-owned hospital established under CEPA according to the Frost & Sullivan Report. Leveraging our first mover advantage and our experience in providing ophthalmic services of international standard in Hong Kong treating a wide range of eye problems from common to rare and complex conditions, we believe we have built one of the leading ophthalmic practices in Shenzhen. Our eye hospital operated by Shenzhen C-MER Hospital ranked third amongst 113 public and private hospitals in Shenzhen in 2016 (overall) and ranked second in the first quarter of 2017 in the quarterly surveys of “Patient Satisfaction” (病人滿意度) conducted by the Shenzhen Health Commission. In addition, we plan to expand our service network in Northern China by establishing Beijing C-MER Hospital, which is expected to commence business operation in Jan 2018.
Our business was founded in Hong Kong in January 2012 by Dr. Dennis LAM, an ophthalmic surgeon with over 30 years of clinical experience. Since then, our business has grown rapidly to include a network of one eye centre and four Satellite Clinics in different locations in Hong Kong, with our Mongkok Surgery Centre and the fifth Satellite Clinic expected to open in the fourth quarter of 2017 and the first quarter of 2018, respectively. According to the Frost & Sullivan Report, our Hong Kong practice under the brand of “C-MER Dennis Lam & Partners (希瑪林順潮眼科中心)” is the second largest eye centre in Hong Kong private ophthalmic service market in 2016 in terms of revenue with a market share of 4.7%, and enjoyed the highest revenue growth in terms of percentages during the period from 2014 to 2016 among the five largest ophthalmic service providers in Hong Kong, achieving a CAGR of 29.6%. We believe our eye hospital operated by Shenzhen C-MER Hospital has also been a success. According to the Frost & Sullivan Report, our eye hospital operated by Shenzhen C-MER Hospital ranked third in the private ophthalmic service market in Guangdong Province in 2016 in terms of revenue with a market share of 5.4%. We specialise in offering treatment and therapy services for ophthalmic diseases, which include, amongst others, cataract, corneal and external eye diseases, glaucoma, vitreoretinal and macular diseases, as well as ancillary treatment by way of acupuncture and traditional Chinese medicine. Our business is led by two of our ophthalmologists with intensive management experience and supported by other management professionals. Guided by our doctor-led management team, we focus on the quality of our ophthalmic services and our patient experience and devote resources to allow our ophthalmologists and physicians to adhere to the international standard of professionalism, ethics and responsibility in providing our ophthalmic services. We are also committed to recruiting qualified ophthalmologists and physicians to form a comprehensive medical team. As of the Latest Practicable Date, we had eight ophthalmologists in Hong Kong (including Dr. Dennis LAM) and 22 physicians in the PRC. Three of our PRC physicians are overseas ophthalmologists resident in the PRC.